Tag: personalized psychiatry market share

Uncover key drivers, emerging technologies, and competitive movements shaping the personalized psychiatry market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Personalized Psychiatry Market expected to reach by 2030?

The personalized psychiatry market size has seen rapid expansion in recent years. It is projected to increase from $6.51 billion in 2025 to $7.46 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.6%. Historically, this growth can be attributed to several factors including increasing awareness of mental health disorders, the expansion of genetic testing in clinical psychiatry, the rising adoption of telepsychiatry services, the growing availability of mental health data platforms, and increasing research funding for psychiatric precision medicine.

The personalized psychiatry market is set for substantial growth over the next few years, with its valuation expected to reach $12.73 billion by 2030, advancing at a compound annual growth rate (CAGR) of 14.3%. This expansion during the forecast period is fueled by an escalating demand for psychiatric interventions that yield clear outcomes, the increasing incorporation of AI and genomics within mental healthcare practices, the proliferation of home-based and digital mental wellness solutions, a heightened emphasis on individualized drug efficacy, and growing investments in platforms dedicated to precision psychiatry. Significant trends for this period include the wider adoption of treatment planning guided by pharmacogenomics, the expanding utilization of AI-powered tools for clinical decision support, the development of personalized care models through telepsychiatry, the rising integration of data from wearables and neuroimaging, and a more concentrated effort on early and accurate diagnoses.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24365&type=smp

What Drivers Are Driving Adoption Within The Personalized Psychiatry Market?

A surge in mental health concerns is projected to fuel the expansion of the personalized psychiatry market in the coming years. These issues encompass various conditions impacting an individual’s emotional, psychological, and social well-being. This rise in mental health challenges stems from heightened stress and lifestyle difficulties, often resulting from rapid work paces, inadequate work-life balance, and insufficient coping strategies. Personalized psychiatry addresses these issues through customized treatment approaches, considering each person’s unique biological, psychological, and lifestyle elements. This approach improves the efficacy of care by minimizing experimental treatment methods, which facilitates quicker recovery and better patient results. For example, US-based health agencies, specifically the National Alliance on Mental Illness and NextStep Solutions Behavioral Health, indicated in 2025 that the prevalence of serious mental illness (SMI) among adults was approximately 5.44% in 2023. Consequently, the growing prevalence of mental health problems is stimulating the expansion of the personalized psychiatry market.

How Is The Personalized Psychiatry Market Organized Into Various Segments?

The personalized psychiatry market covered in this report is segmented –

1) By Type: Products, Services, Software

2) By Technology: Genetic Testing, Artificial Intelligence, Neurostimulation Technology, Digital Therapeutics

3) By Application: Depression, Anxiety Disorders, Bipolar Disorder, Schizophrenia, Attention-Deficit Hyperactivity Disorder (ADHD)

4) By End User: Clinics, Hospitals, Research Institutes, Homecare Settings

Subsegments:

1) By Products: Pharmacogenomic Test Kits, Wearable Devices, Brain Imaging Devices

2) By Services: Telepsychiatry, Personalized Treatment Planning, Behavioral Assessment

3) By Software: Clinical Decision Support Tools, Mental Health Apps, Virtual Therapy Platforms

Which Market Trends Are Opening Growth Opportunities In The Personalized Psychiatry Market?

Major companies operating in the personalized psychiatry market are increasingly focused on developing technologically advanced services, such as personalized telepsychiatry services, to improve access to individualized mental health care through a flexible, patient-centered model. Personalized telepsychiatry service represents a remote mental healthcare approach that delivers tailored psychiatric evaluation and treatment, based on an individual’s unique genetic, environmental, and lifestyle factors, via digital communication platforms. For instance, in April 2025, Alice’s Psychiatry & Wellness, a US-based psychiatry and wellness service company, inaugurated a clinic to offer compassionate, personalized psychiatric care to adults across multiple states, utilizing both in-person and telepsychiatry services. This clinic integrates pharmacogenetic testing to customize psychiatric medications according to each patient’s genetic profile, thereby enhancing treatment effectiveness and reducing adverse effects. The clinic leverages virtual platforms and continuous care from a dedicated provider to deliver mental health support that is accessible, consistent, and inclusive, fully aligning with the principles of personalized psychiatry.

Who Are The Top-Performing Companies In The Personalized Psychiatry Market In Recent Years?

Major companies operating in the personalized psychiatry market are Johnson & Johnson, AbbVie Inc., Bristol-Myers Squibb, Takeda Pharmaceutical Company, Boehringer Ingelheim, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S, Neurocrine Biosciences, Spring Health, Neumora Therapeutics Inc., Atai Life Sciences, Valera Health, Compass Pathways, Genomind, Woebot Health, Meru Health, Alto Neuroscience, Arcara Personalized Psychiatry, Mind Sync Therapeutics, Starling Minds, HMNC Holding GmbH, Pear Therapeutics, Akili Interactive

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/personalized-psychiatry-global-market-report

Which Region Currently Holds The Largest Share Of The Personalized Psychiatry Market?

North America was the largest region in the personalized psychiatry market in 2025. The regions covered in the personalized psychiatry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Personalized Psychiatry Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24365&type=smp

Browse Through More Reports Similar to the Global Personalized Psychiatry Market 2026, By The Business Research Company

General Medical And Surgical Hospitals Market Report 2026

https://www.thebusinessresearchcompany.com/report/general-medical-and-surgical-hospitals-global-market-report

Psychiatrists Market 2026

https://www.thebusinessresearchcompany.com/report/psychiatrists-market

Personalized Learning Market Report 2026

https://www.thebusinessresearchcompany.com/report/personalized-learning-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Is The Personalized Psychiatry Market Expected To Grow In Terms Of Size?

The scale of the personalized psychiatry market has swiftly expanded in the past few years. The market is projected to escalate from $5.69 billion in 2024 to $6.51 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 14.5%. Factors such as growing awareness towards mental health, an increase in the occurrence of psychiatric disorders, a surge in the demand for personalized healthcare, increased healthcare expenses, and improved healthcare accessibility and affordability have contributed to this historical period’s growth.

The market size for personalized psychiatry is predicted to experience swift expansion in the coming years, growing to $11.16 billion by 2029 at a compound annual growth rate of 14.4%. The growth predicted for the forecast period is linked to the increased application of digital therapeutics, the expanding necessity for monitoring patients remotely, the escalating demand for mental health solutions subsequent to the COVID-19 outbreak, surging government and private sector funding in mental health, and the need for more readily available mental healthcare solutions. Key trends for the forecast period comprise of the strengthened utilization of artificial intelligence in mental health diagnosis, growing favorability of telepsychiatry and online consultations, implementation of blockchain for securing mental health data, the rising application of virtual reality (VR) for therapeutic treatments, and advancement of wearable devices for monitoring mental health.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24365&type=smp

Which Key Factors Are Fueling Growth In The Personalized Psychiatry Market?

The personalized psychiatry market is anticipated to scale alongside the surge in mental health issues. Generally defined, mental health problems include a variety of conditions that impact one’s emotional, psychological, and social welfare. Such mental health problems are becoming increasingly prevalent due to the escalating stress levels and lifestyle-related challenges – these are often a consequence of demanding work settings, inadequate work-life equilibrium, and insufficient coping strategies. Personalized psychiatry tackles these mental health issues by devising treatment schemes customized to each individual’s biological, psychological, and lifestyle factors. This model of care augments its effectiveness by eliminating the uncertainty in treatment options, thus enabling more swift recovery and superior patient results. For example, 2022 saw 59.3 million US adults, aged 18 or more, diagnosed with any mental illness (AMI), as per the National Institute of Mental Health, a federal government research agency in the US. This group formed 23.1% of the total adult population of the nation. Hence, the escalating mental health problems are propelling the growth of the personalized psychiatry market.

How Is The Personalized Psychiatry Market Categorized Across Applications And Types?

The personalized psychiatrymarket covered in this report is segmented –

1) By Type: Products; Services; Software

2) By Technology: Genetic Testing; Artificial Intelligence; Neurostimulation Technology; Digital Therapeutics

3) By Application: Depression; Anxiety Disorders; Bipolar Disorder; Schizophrenia; Attention-Deficit Hyperactivity Disorder (ADHD)

4) By End User: Clinics; Hospitals; Research Institutes; Homecare Settings

Subsegments:

1) By Products: Pharmacogenomic Test Kits; Wearable Devices; Brain Imaging Devices

2) By Services: Telepsychiatry; Personalized Treatment Planning; Behavioral Assessment

3) By Software: Clinical Decision Support Tools; Mental Health Apps; Virtual Therapy Platforms

Which Emerging Trends Are Reshaping The Personalized Psychiatry Market Landscape?

Leading enterprises in the personalized psychiatry sector are concentrating on advancing their services by utilizing cutting-edge technology, such as bespoke telepsychiatry services. This is to enhance the availability of tailored mental health care through a versatile, patient-centric service model. Personalized psychiatry service is a distant mental health care approach that offers customized psychiatric evaluation and treatment that reflects the unique genetic, environmental, and lifestyle factors of an individual. It uses digital communication platforms extensively. For example, Alice’s Psychiatry & Wellness, a US-based company specializing in psychiatry and wellness services, initiated a clinic in April. They aimed to offer compassionate, individualized psychiatric care to adults in various states, through both face-to-face and telepsychiatry services. This clinic introduces pharmacogenetic testing to align psychiatric medicines with each patient’s genetic profile, thereby boosting treatment efficacy and cutting down on side effects. The clinic leverages digital platforms and offers persistent care from a committed provider to provide accessible and inclusive mental health support. This completely aligns with the principles of personalized psychiatry.

Which Firms Are Making The Biggest Impact In The Personalized Psychiatry Market?

Major companies operating in the personalized psychiatry market are Johnson & Johnson, AbbVie Inc., Bristol-Myers Squibb, Medtronic Plc, Takeda Pharmaceutical Company, Boehringer Ingelheim, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S, Neurocrine Biosciences, Spring Health, Neumora Therapeutics Inc., Atai Life Sciences, Valera Health, Compass Pathways, Genomind, Woebot Health, BrightQuest Treatment Centers, Meru Health, Alto Neuroscience, Arcara Personalized Psychiatry, GreyBird Ventures, Mind Sync Therapeutics, Starling Minds, HMNC Holding GmbH.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/personalized-psychiatry-global-market-report

Which Region Holds The Greatest Opportunity For Personalized Psychiatry Market Expansion?

North America was the largest region in the personalized psychiatry market in 2024. The regions covered in the personalized psychiatry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=24365&type=smp

Browse Through More Reports Similar to the Global Personalized Psychiatry Market 2025, By The Business Research Company

Telepsychiatry Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/telepsychiatry-global-market-report

Ai In Mental Health Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ai-in-mental-health-global-market-report

Behavioral And Mental Health Software Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/behavioral-and-mental-health-software-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Personalized Psychiatry Market From 2025 To 2034?

The personalized psychiatry market size has demonstrated rapid expansion in recent years. It is anticipated to grow from $5.69 billion in 2024 to $6.51 billion in 2025, advancing at a compound annual growth rate (CAGR) of 14.5%. The historical development of this market can be attributed to heightened awareness concerning mental health, a growing prevalence of psychiatric disorders, an increasing demand for personalized healthcare solutions, rising healthcare expenditures, and improved healthcare access along with affordability.

The personalized psychiatry market is projected to experience substantial growth in the upcoming years. Its valuation is forecast to reach $11.16 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 14.4%. This anticipated growth during the forecast period can be attributed to several factors, including the increasing application of digital therapeutics, a greater need for remote patient monitoring, a surge in demand for mental health solutions post-COVID-19, enhanced investments in mental health from both government and private sectors, and the desire for more readily available mental healthcare options. Key trends expected during the forecast period encompass a more advanced utilization of artificial intelligence for diagnosing mental health conditions, the rising adoption of telepsychiatry and virtual consultations, the incorporation of blockchain technology for securing mental health data, an increase in the deployment of virtual reality (VR) for therapeutic purposes, and the proliferation of wearable devices for tracking mental health.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24365&type=smp

Which Drivers Are Shaping The Personalized Psychiatry Industry’s Market Share?

The escalating prevalence of mental health challenges is projected to drive the expansion of the personalized psychiatry market in the future. These issues encompass a broad spectrum of conditions impacting an individual’s emotional, psychological, and social welfare. The rise in mental health concerns stems from escalating stress and lifestyle factors, primarily attributed to demanding work environments, an imbalance between work and personal life, and insufficient coping mechanisms. Personalized psychiatry addresses mental health conditions by providing customized treatment regimens that consider a patient’s unique biological, psychological, and lifestyle attributes. This approach improves the efficacy of care, minimizing experimental treatments and resulting in quicker recovery periods and better patient outcomes. As an illustration, data from the National Institute of Mental Health, a US-based federal government research agency, revealed that in 2022, approximately 59.3 million adults aged 18 and older in the United States were estimated to be experiencing any mental illness (AMI), representing 23.1% of the overall adult populace. Consequently, the growing incidence of mental health problems is propelling the expansion of the personalized psychiatry market.

What Are The Primary Types Of Segments Analyzed In The Personalized Psychiatry Market?

The personalized psychiatrymarket covered in this report is segmented –

1) By Type: Products; Services; Software

2) By Technology: Genetic Testing; Artificial Intelligence; Neurostimulation Technology; Digital Therapeutics

3) By Application: Depression; Anxiety Disorders; Bipolar Disorder; Schizophrenia; Attention-Deficit Hyperactivity Disorder (ADHD)

4) By End User: Clinics; Hospitals; Research Institutes; Homecare Settings

Subsegments:

1) By Products: Pharmacogenomic Test Kits; Wearable Devices; Brain Imaging Devices

2) By Services: Telepsychiatry; Personalized Treatment Planning; Behavioral Assessment

3) By Software: Clinical Decision Support Tools; Mental Health Apps; Virtual Therapy Platforms

What Key Innovation Trends Are Fueling Advancements In The Personalized Psychiatry Market?

Major companies in the personalized psychiatry market are concentrating on developing technologically advanced services, such as personalized telepsychiatry services, to improve access to individualized mental health care via a flexible, patient-centered service model. Personalized telepsychiatry offers a remote mental healthcare approach that delivers tailored psychiatric evaluation and treatment, informed by an individual’s unique genetic, environmental, and lifestyle factors, through digital communication platforms. For instance, in April 2025, Alice’s Psychiatry & Wellness, a US-based psychiatry and wellness service company, inaugurated a clinic to provide compassionate, personalized psychiatric care for adults across multiple states, utilizing both in-person and telepsychiatry services. This clinic integrates pharmacogenetic testing to customize psychiatric medications based on each patient’s genetic profile, thereby enhancing treatment effectiveness and reducing adverse effects. The clinic further leverages virtual platforms and continuous care from a dedicated provider to deliver accessible, consistent, and inclusive mental health support, aligning fully with the principles of personalized psychiatry.

Who Are The Major Companies Operating In The Personalized Psychiatry Market?

Major companies operating in the personalized psychiatry market are Johnson & Johnson, AbbVie Inc., Bristol-Myers Squibb, Medtronic Plc, Takeda Pharmaceutical Company, Boehringer Ingelheim, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S, Neurocrine Biosciences, Spring Health, Neumora Therapeutics Inc., Atai Life Sciences, Valera Health, Compass Pathways, Genomind, Woebot Health, BrightQuest Treatment Centers, Meru Health, Alto Neuroscience, Arcara Personalized Psychiatry, GreyBird Ventures, Mind Sync Therapeutics, Starling Minds, HMNC Holding GmbH.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/personalized-psychiatry-global-market-report

Which Region Is Projected To Lead The Personalized Psychiatry Market During The Forecast Period?

North America was the largest region in the personalized psychiatry market in 2024. The regions covered in the personalized psychiatry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Personalized Psychiatry Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24365&type=smp

Browse Through More Reports Similar to the Global Personalized Psychiatry Market 2025, By The Business Research Company

Telepsychiatry Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/telepsychiatry-global-market-report

Ai In Mental Health Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ai-in-mental-health-global-market-report

Behavioral And Mental Health Software Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/behavioral-and-mental-health-software-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Milestones in the Personalized Psychiatry Market’s Growth Trajectory From 2025 To 2034?

The market size for personalized psychiatry has seen swift expansion in the past few years. It is predicted to rise from $5.69 billion in 2024 to $6.51 billion in 2025, boasting a compound annual growth rate (CAGR) of 14.5%. This considerable growth in the historical period can be ascribed to the heightening awareness about mental health, escalating occurrence of psychiatric conditions, surging need for individualized healthcare, growing health care investments, as well as the enlarging accessibility and affordability of health care.

Anticipations foresee significant expansion for the personalized psychiatry sector, with projected growth to reach a value of $11.16 billion by 2029, demonstrating a Compound Annual Growth Rate (CAGR) of 14.4%. The primary drivers fueling this prospective surge encompass the rise in digital therapeutics utilization, increasing need for patient monitoring remotely, escalating demand for mental health solutions post-COVID-19, increased investment in mental health by governmental and private sector entities, and accessible mental healthcare solutions becoming more desirable. Key trends that can be expected within the forecast timeline include leveraging artificial intelligence for mental health diagnosis more, an uptick in the popularity of telepsychiatry and online consultations, incorporating blockchain in securing mental health data, increased usage of Virtual Reality (VR) as a part of therapeutic procedures, and the proliferation of wearable devices monitoring mental health.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24365&type=smp

What External and Internal Drivers Are Contributing to the Growth of thePersonalized Psychiatry Market?

Predicted advancements in the personalized psychiatry market are being spurred on by the escalating prevalence of mental health disorders. Manifested in varying emotional, psychological, and social effects, mental health disorders are predominantly fuelled by mounting pressure, lifestyle-derived problems associated with relentless professional commitments, inadequate work-life harmony, and lacking stress-management strategies. Personalized psychiatry plays a key role in combating mental health disorders by incorporating individualized treatment plans, taking into account each patient’s biological, psychological, and lifestyle distinctiveness. This strategic approach enhances the efficacy of care by eradicating guesswork in treatments, thus promoting quicker rehabilitation and better patient results. Illustratively, in 2022, the National Institute of Mental Health – a research entity under the federal government of the United States, reported that an estimated total of 59.3 million adults aged 18 or more in the United States were diagnosed with any mental illness (AMI), representing 23.1% of the entire adult citizenry. Consequently, the surge in mental health disorders is propelling the growth of the personalized psychiatry market.

What Segment Types Define the Personalized Psychiatry Market Structure?

The personalized psychiatrymarket covered in this report is segmented –

1) By Type: Products; Services; Software

2) By Technology: Genetic Testing; Artificial Intelligence; Neurostimulation Technology; Digital Therapeutics

3) By Application: Depression; Anxiety Disorders; Bipolar Disorder; Schizophrenia; Attention-Deficit Hyperactivity Disorder (ADHD)

4) By End User: Clinics; Hospitals; Research Institutes; Homecare Settings

Subsegments:

1) By Products: Pharmacogenomic Test Kits; Wearable Devices; Brain Imaging Devices

2) By Services: Telepsychiatry; Personalized Treatment Planning; Behavioral Assessment

3) By Software: Clinical Decision Support Tools; Mental Health Apps; Virtual Therapy Platforms

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=24365&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Personalized Psychiatry Market?

North America was the largest region in the personalized psychiatry market in 2024. The regions covered in the personalized psychiatry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Personalized Psychiatry Market?

Top firms involved in the specialized psychiatry market are focusing on the creation of highly advanced services, including bespoke telepsychiatry services, as a way to increase availability to individual mental health care via a flexible, patient-focused service structure. Personalized telepsychiatry service offers a distance-based mental healthcare solution, providing customized psychiatric assessment and therapy, taking into consideration the unique combination of an individual’s genetic, environmental, and lifestyle circumstances, facilitated by digital mediums. To illustrate, Alice’s Psychiatry & Wellness, a psychiatry and wellness service agency based in the U.S., inaugurated a clinic in April 2025. The purpose of this clinic is to deliver compassionate, tailor-made psychiatric care to adults from various states, both in person and via telepsychiatry services. This clinic employs pharmacogenetic testing to customize psychiatric medications to each patient’s genetic makeup, thereby increasing therapy effectiveness and minimizing side effects. To ensure accessible, consistent, and inclusive mental health support, the clinic makes use of virtual mediums and constant care from a dedicated provider, completely in tune with the ideals of specialized psychiatry.

View the full report here:

https://www.thebusinessresearchcompany.com/report/personalized-psychiatry-global-market-report

What Is the Definition of the Personalized Psychiatry Market?

Personalized psychiatry is a tailored approach to mental health care that integrates genetic, biological, environmental, and clinical data to customize diagnosis, treatment planning, and therapeutic interventions for individual patients, aiming to improve outcomes and reduce trial-and-error prescribing. It is used to enhance treatment efficacy, minimize adverse effects, and facilitate early intervention by aligning psychiatric care with an individual patient’s unique biological and psychological profile.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24365

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

We’ve updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

How Has The Personalized Psychiatry Market Size Shifted, And What Is the Outlook Through 2034?

The market size for personalized psychiatry has seen a swift expansion in recent times. It’s projected to escalate from $5.69 billion in 2024 to about $6.53 billion in 2025, with a compound annual growth rate (CAGR) of 14.8%. The growth witnessed during the historical period is due to heightened awareness of mental health, increasing incidence of psychiatric disorders, surging demand for tailored healthcare, increased healthcare spending, and improved accessibility and affordability of healthcare.

The market size of personalized psychiatry is anticipated to experience accelerated expansion in the forthcoming years, surging to $11.24 billion in 2029 at a 14.6% compound annual growth rate (CAGR). The projected growth is credited to a variety of factors including the increasing application of digital therapeutics, the growing necessity of remote patient tracking, higher demand for mental health solutions following the COVID-19 pandemic, greater investments in mental health by both the public and private sectors, and the requirement for more easily accessible mental healthcare solutions. Key trends during the forecast period encompass the improved application of artificial intelligence in mental health diagnosis, widespread acceptance of telepsychiatry and online consultations, along with the integration of blockchain for data security in mental health, augmented use of virtual reality (VR) for therapeutic interventions, and the proliferation of wearable devices for mental health tracking.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24365&type=smp

What Are the Core Market Drivers Propelling Growth in the Personalized Psychiatry Industry?

Surging mental health problems are anticipated to spur the expansion of the personalized psychiatry market in the future. These challenges encompass a broad spectrum of conditions impacting an individual’s emotional, social, and psychological health. The escalation in mental health troubles can be attributed to the increase in stress and lifestyle-related obstacles, propelled by demanding work settings, inadequate work-life harmony, and scarce resilience strategies. Personalized psychiatry addresses these problems by providing customized treatment options that consider unique biological, psychological, and lifestyle influences. This targeted approach enhances the efficacy of care by minimizing guesswork in treatment strategies, thus enabling quicker recovery and better patient results. For example, in 2022, the National Institute of Mental Health, a research agency of the US federal government, estimated that 59.3 million adults aged 18 and up in the United States were suffering from any mental illness (AMI), making up 23.1% of the total adult population. Hence, the surge in mental health problems is fueling the expansion of the personalized psychiatry market.

How Is the Personalized Psychiatry Market Segmented?

The personalized psychiatry market covered in this report is segmented –

1) By Type: Products, Services, Software

2) By Technology: Genetic Testing, Artificial Intelligence, Neurostimulation Technology, Digital Therapeutics

3) By Application: Depression, Anxiety Disorders, Bipolar Disorder, Schizophrenia, Attention-Deficit Hyperactivity Disorder (ADHD)

4) By End User: Clinics, Hospitals, Research Institutes, Homecare Settings

Subsegments:

1) By Products: Pharmacogenomic Test Kits, Wearable Devices, Brain Imaging Devices

2) By Services: Telepsychiatry, Personalized Treatment Planning, Behavioral Assessment

3) By Software: Clinical Decision Support Tools, Mental Health Apps, Virtual Therapy Platforms

Request customized data on this market:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24365&type=smp

Which Regions Are Driving the Next Phase of the Personalized Psychiatry Market Growth?

North America was the largest region in the personalized psychiatry market in 2024. The regions covered in the personalized psychiatry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Personalized Psychiatry Industry?

In the personalized psychiatry market, key business players are concentrating their efforts on introducing advanced technology services such as bespoke telepsychiatry services. These are aimed at boosting access to personalized mental health care through a flexible, patient-centric service model. Personalized telepsychiatry services provide specialized psychiatric evaluation and treatment digitally, tailored to fit an individual’s unique genetic, environmental, and lifestyle factors. For instance, US-based psychiatry and wellness service company, Alice’s Psychiatry & Wellness, inaugurated a clinic in April 2025 that offers empathetic, customized psychiatric care to adults across different states via both face-to-face and telepsychiatry services. The clinic utilizes pharmacogenetic testing to individualize psychiatric medications according to each patient’s genetic makeup, thereby improving treatment efficacy and minimizing detrimental side effects. Through the use of digital platforms and continuous support from a dedicated provider, the clinic offers accessible, consistent, and inclusive mental health support, a reflection of the key principles of personalized psychiatry.

View the full report here:

https://www.thebusinessresearchcompany.com/report/personalized-psychiatry-global-market-report

How Is the Personalized Psychiatry Market Defined and What Are Its Core Parameters?

Personalized psychiatry is a tailored approach to mental health care that integrates genetic, biological, environmental, and clinical data to customize diagnosis, treatment planning, and therapeutic interventions for individual patients, aiming to improve outcomes and reduce trial-and-error prescribing. It is used to enhance treatment efficacy, minimize adverse effects, and facilitate early intervention by aligning psychiatric care with an individual patient’s unique biological and psychological profile.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/customise?id=24365&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model